Craft
SpectralMD

SpectralMD

Revenue

$15.2 M

FY, 2021

Market Capitalization

£44.3 M

2023-02-03

SpectralMD Summary

Company summary

Overview
SpectralMD is a medical device company that develops technology using predictive analytics and AI algorithms. It provides DeepView, a wound imaging system that allows for immediate wound healing assessment and provides clinicians with physiological information.
Type
Public
Status
Active
Founded
2009
HQ
Dallas, TX, US | view all locations
Website
https://www.spectralmd.com
Cybersecurity rating
Sectors

Key people

  • Martin Mellish

    Martin Mellish, Independent Non-Executive Chairman

    • Gerry Beaney

      Gerry Beaney, Independent Non-Executive Director

      • Cynthia Cai

        Cynthia Cai, Independent Non-Executive Director

        • Richard Cotton

          Richard Cotton, Independent Non-Executive Director

          LocationsView all

          2 locations detected

          • Dallas, TX HQ

            United States

            2515 McKinney Avenue Suite 1000

          • London, England

            United Kingdom

            Two Kingdom Street 6th Floor

          SpectralMD Financials

          Summary financials

          Revenue (H1, 2022)
          $12.3M
          Gross profit (H1, 2022)
          $5.2M
          Net income (H1, 2022)
          ($626.0K)
          Cash (H1, 2022)
          $15.6M
          EBIT (H1, 2022)
          ($460.0K)
          Enterprise value
          $29.0M

          Footer menu